Browse 122 retinitis pigmentosa clinical trials enrolling across the United States and Canada. Search by city or state to find one near you.
Retinitis pigmentosa usually begins with trouble seeing at night and slowly narrows side vision, and more than 100 genes have been linked to it. The eye was the site of a medical first: in 2017 the FDA approved its first gene therapy for an inherited disease, for vision loss caused by one of those genes. Most people with retinitis pigmentosa have a different gene change and still no approved treatment. Gene therapies, cell therapies, and treatments that work regardless of the gene are now in trials, and genetic testing is the first step toward them.
The Effects of Disulfiram (Antabuse®) on Visual Acuity in Patients With Retinal Degeneration
for
Alcohol Use Disorder, Retinal Dystrophies,
Location: Rochester NY
Sponsor: University of Rochester
Sex: All
Age: 18+
Code: NCT06319872
Phase 1, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
BS01 in Patients With Retinitis Pigmentosa
for
Retinitis Pigmentosa
Location: Teaneck NJ
Sponsor: Bionic Sight LLC
Sex: All
Age: 18+
Code: NCT04278131
Phase 1, Phase 2, Recruiting
Observational Study of the Argus® II Retinal Prosthesis System
for
Retinitis Pigmentosa
Location: Toronto
Sponsor: University Health Network, Toronto
Sex: All
Age: 25+
Code: NCT01999049
Recruiting
A Natural History Study Seeks to Understand the Clinical, Genomic, Pharmacological, Laboratory, and Dietary Determinates of Pyrimidine and Purine Metabolism Disorders
for
AMPD3, OMIM*102772, AMP Deaminase Deficiency,
Location: Bethesda MD
Sponsor: National Human Genome Research Institute (NHGRI)
Sex: All
Age: 0 - 70+
Code: NCT06092346
Recruiting
Study of BEST1 Vitelliform Macular Dystrophy
for
Best Vitelliform Macular Dystrophy, Retinitis Pigmentosa
Location: New York NY
Sponsor: Columbia University
Sex: All
Age: 0+
Code: NCT05809635
Recruiting
Brain Stimulation Effects on Orientation and Mobility Skills in Adults With Vision Impairment
for
Retinitis Pigmentosa (RP), Rod Cone Dystrophy,
Location: Waterloo
Sponsor: University of Waterloo
Sex: All
Age: 18+
Code: NCT07341763
Recruiting
Retinal Imaging in Patients With Inherited Retinal Degenerations
for
Retinitis Pigmentosa
Location: San Francisco CA
Sponsor: University of California, San Francisco
Sex: All
Age: 13+
Code: NCT00254605
Recruiting
High Resolution Retinal Imaging
for
Stargardts, Retinitis Pigmentosa,
Location: Philadelphia PA
Sponsor: University of Pennsylvania
Sex: All
Age: 7+
Code: NCT01866371
Recruiting
A Study to Investigate the Safety of DSP-3077 After a Unilateral Eye Injection in Male and Female Participants 18 Years of Age or Older With Retinitis Pigmentosa
for
Retinitis Pigmentosa
Location: Boston MA, Minneapolis MN
Sponsor: Sumitomo Pharma America, Inc.
Sex: All
Age: 18+
Code: NCT06891885
Phase 1, Phase 2, Recruiting
Virtual Reality Mobility Assessment of Functional Vision in Retinal Disease
for
Cone-Rod Degeneration, Rod-Cone Degeneration
Location: Bethesda MD
Sponsor: National Eye Institute (NEI)
Sex: All
Age: 5 - 70+
Code: NCT04289571
Phase 1, Recruiting
Experimental and Clinical Studies of Retinal Stimulation